Ping An Biomedical (PASW)

The group provides an integrated service platform covering multiple stages of textile and garment supply. Its offerings include market trend analysis, product design and development, raw material sourcing, production oversight, quality control, and logistics coordination. By working across these functions, the company aims to help customers manage product development and manufacturing processes more efficiently, from initial concept through delivery.

Ping An Biomedical reports its business through two main segments: yarns and finished garments. The yarns segment accounts for the majority of revenue and includes products such as pure cashmere yarn, cashmere-blend yarn, merino wool, cotton, and specialty or fancy yarns. These materials are used by apparel manufacturers and brands that require specific texture, performance, or design characteristics. The finished garments segment extends the company’s role further down the supply chain by supporting the production and delivery of completed apparel products.

The company’s position is shaped by relationships across suppliers, manufacturers, and end customers in the textile market. Its business is exposed to fashion cycles, raw material availability, pricing trends, and demand from apparel brands. For investors, Ping An Biomedical represents a listed vehicle tied to textile supply chain services, with an emphasis on yarn sourcing and coordination rather than a pure manufacturing or retail model.